Blazer™ Dx-20 M00420SL2820Recalls & reported problems
Boston Scientific Corporation · Bidirectional Steerable Diagnostic Catheter · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08714729780519), received between Dec 4, 2019 and Dec 4, 2019 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Cardiac Tamponade1
- Low Blood Pressure/ Hypotension1
- Pericardial Effusion1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryDec 4, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PATIENT EXPERIENCED A CARDIAC TAMPONADE AND EFFUSION. DURING AN ABLATION PROCEDURE TO TREAT ATRIAL TACHYCARDIA, AFTER PLACING THE CATHETERS IN THE CORONARY SINUS (CS), "HRA", "HIS", RIGHT VENTRICLE (RV) AND "HALO," MAPPING WAS PERFORMED WITH AN INTELLAMAP ORION CATHETER, AND RADIOFREQUENCY (RF) ABLATION WAS PERFORMED USING AN INTELLANAV MIFI OPEN-IRRIGATED ABLATION CATHETER. A BLAZER DX CATHETER WAS PLACED RIGHT ATRIUM VENTRICULAR FREE-WALL SIDE, AND UNDERWENT AN ELECTROPHYSIOLOGY STUDY (EPS). FOUR OTHER NON-BOSTON SCIENTIFIC CATHETERS WERE ALSO USED DURING THE PROCEDURE. AFTER THE PROCEDURE, WHEN THE INTELLANAV MIFI OPEN-IRRIGATED ABLATION CATHETER WAS COMPLETELY PULLED OUT FROM THE PATIENT'S BODY, AND HEMOSTASIS WAS PERFORMED AT THE GROIN, THE PATIENT'S BLOOD PRESSURE DROPPED RAPIDLY. A CARDIAC TAMPONADE WAS OBSERVED BY ECHOCARDIOGRAM, SO PERICARDIAL DRAINAGE WAS PERFORMED. ALTHOUGH THE PHYSICIAN DID NOT KNOW THE CAUSE OF THE EFFUSION, THERE WAS POSSIBILITY THAT PERFORATION MIGHT HAVE BEEN CAUSED BECAUSE THE ATRIAL WALL ON ABLATION SITE WAS THIN. IT WAS UNKNOWN WHICH CATHETER CAUSED OR CONTRIBUTED TO THE EVENT. NO RESISTANCE WAS FELT WHILE MANEUVERING THE
Patient problems: Cardiac Tamponade; Low Blood Pressure/ Hypotension; Pericardial Effusion
MAUDE report 9410676 ↗
Other CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING devices
- Advisor™ HD Grid, Sensor Enabled™ D-AVHD-DF16St. Jude Medical, Inc. · CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING6 deaths358 reports
- IntellaMap Orion™ M004RC64S0Boston Scientific Corporation · CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING6 deaths356 reports
- ACHIEVE™ 990063-020Medtronic, Inc. · CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING7 deaths129 reports
- Inquiry™ IBI-81104Irvine Biomedical, Inc. · CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING1 recall2 deaths64 reports
- DECANAV R7F282CTBiosense Webster Inc · CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING4 deaths108 reports
- LASSO NAV D134301Biosense Webster Inc · CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING2 deaths82 reports
- DECANAV R7D282CTBiosense Webster Inc · CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING1 death75 reports
- ACHIEVE ADVANCE™ 2ACH20Medtronic, Inc. · CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING3 deaths69 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page